Skip to main content

Table 1 Characteristics of the study population

From: Effects of L-carnitine supplementation on nutritional, immunological, and cardiac parameters in hemodialysis patients: a pilot study

No.

21

Duration of hemodialysis (months)

60 ± 84

Age (years)

73.5 ± 11.6

Gender (male/female)

12/9

Dry weight (kg)

48.0 ± 12.5

Body height (cm)

158.0 ± 10.5

BMI (kg/m2)

19.0 ± 3.2

Comorbidity

 

 Cardiovascular disease (%)

23.8

 Cerebral vascular disease (%)

19.0

 HCV Ab-positivity (%)

19.0

Laboratory parameters

 

 Blood urea nitrogen (mg/dL)

47.5 ± 15.5

 Creatinine (mg/dL)

6.9 ± 2.8

 β2-MG (mg/L)

25.0 ± 8.1

 Intact PTH (pg/mL)

90 ± 88

  1. Data, means ± SD
  2. BMI body mass index, HCV Ab anti-hepatitis C antibody, β 2 -MG β2-microglobulin, PTH parathyroid hormone, SD standard deviation